Bibliothèque

Stage III-IV thymic squamous cell carcinoma in complete pathological remission achieved with thymic cancer resection after immunotherapy combined with chemotherapeutic conversion therapy: a report of two cases from real-world data.

BACKGROUND: Thymic carcinoma, a rare malignancy in the mediastinum, currently lacks standardized treatment options. Although surgery remains a crucial component among traditional therapeutic approache…

Thérapies de Conversion

Li, D., Minervini, F., Planas, G., Okuda, K., Ozeki, N., & Zou, Y. (2024). Stage III-IV thymic squamous cell carcinoma in complete pathological remission achieved with thymic cancer resection after immunotherapy combined with chemotherapeutic conversion therapy: a report of two cases from real-world data.. Gland Surg, 13(1), 117-127. https://doi.org/10.21037/gs-23-488

29/01/2024 Lire →

Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review.

Hepatocellular carcinoma (HCC) ranks as the sixth most common malignancy globally, with the majority of patients presenting at the initial diagnosis with locally advanced or metastatic disease, preclu…

Thérapies de Conversion

Ai, H., Gong, T., Ma, Y., Ma, G., Ding, W., Ding, W., Wang, W., & Zhao, X. (2024). Transarterial chemoembolization combined with atezolizumab plus bevacizumab conversion therapy for intermediate-stage hepatocellular carcinoma: a case report and literature review.. Front Immunol, 15, 1358602. https://doi.org/10.3389/fimmu.2024.1358602

01/01/2024 Lire →

Surgical Treatment After Conversion Therapy in a Patient With Massive Hepatocellular Carcinoma.

Thérapies de Conversion

Fu, M. . M. . L., Jiang, M. . M. . J., Liu, M. . M. . M., Li, M. . M. . J., & Zhu, M. . D. . H. (2024). Surgical Treatment After Conversion Therapy in a Patient With Massive Hepatocellular Carcinoma.. Gastroenterol Nurs, 47(3), 222-228. https://doi.org/10.1097/SGA.0000000000000770

01/01/2024 Lire →

Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.

PURPOSE: The aim of this study was to investigate the efficacy and safety of conversion surgery for advanced hepatocellular carcinoma (HCC) after hepatic arterial infusion chemotherapy (HAIC).PATIENTS…

Thérapies de Conversion

Li, W., Zheng, Z., Wang, J., Wu, T., Wang, J., Pan, Y., Chen, J., Hu, D., Xu, L., Zhang, Y., Chen, M., & Zhou, Z. (2024). Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy.. J Hepatocell Carcinoma, 11, 463-475. https://doi.org/10.2147/JHC.S447387

01/01/2024 Lire →

Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study.

BACKGROUND: This study evaluates the efficacy of alpha-fetoprotein (AFP) response as a surrogate marker for determining recurrence-free survival (RFS) in patients with unresectable hepatocellular carc…

Thérapies de Conversion

Lin, K. Y., Zhang, J. X., Lin, Z. W., Chen, Q. J., Luo, L. P., Chen, J. H., Wang, K., Tai, S., Zhang, Z. B., Wang, S. F., Li, J. D., Wang, K., Zheng, L., Zheng, S. M., Wu, M. M., Lin, K. C., Yang, T., & Zeng, Y. Y. (2024). Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study.. Front Immunol, 15, 1308543. https://doi.org/10.3389/fimmu.2024.1308543

01/01/2024 Lire →

Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy.

OBJECTIVE: To explore the prognostic impact of contrast-enhanced ultrasound (CEUS) features for initially unresectable colorectal liver metastases (CLMs) in a clinical setting of conversion therapy.ME…

Thérapies de Conversion

Zhang, X. L., Wang, H. T., Tang, Y., Lu, Q., Yuan, H. X., Wang, X., Liu, L. H., Zhu, D. X., & Wang, W. P. (2024). Colorectal liver metastases: Correlations of contrast-enhanced ultrasound features with tumor clinicopathological factors and clinical outcomes following conversion therapy.. Clin Hemorheol Microcirc, 86(3), 339-356. https://doi.org/10.3233/CH-231963

01/01/2024 Lire →

Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.

Hepatocellular carcinoma (HCC) represents a significant global health burden, particularly in the Asia-Pacific region, where it is a leading cause of cancer-related mortality. In China alone, HCC acco…

Thérapies de Conversion

Song, P., Tang, W., & Kokudo, N. (2024). Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China.. Biosci Trends, 18(6), 495-496. https://doi.org/10.5582/bst.2024.01423

01/01/2024 Lire →

Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.

Pancreatic cancer remains a highly malignant and challenging tumor with a dismal 5-year survival rate of only 13%. The majority of patients are diagnosed at advanced stages, where surgical options are…

Thérapies de Conversion

Liu, H., Wang, Y., Zhang, Q., & Ke, N. (2024). Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.. Front Oncol, 14, 1458517. https://doi.org/10.3389/fonc.2024.1458517

01/01/2024 Lire →

A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.

PURPOSE: The purpose of This study is exploring the intraoperative and perioperative differences between patients undergoing conversion surgery and those undergoing direct surgery, so as to improve pr…

Thérapies de Conversion

Li, X., Chen, K., Feng, X., Wu, X., Qi, S., Wang, Q., & Shi, Z. (2024). A Comparative Study of Surgical Approaches for Hepatocellular Carcinoma: Conversion versus Direct Resection.. J Hepatocell Carcinoma, 11, 2101-2113. https://doi.org/10.2147/JHC.S483397

01/01/2024 Lire →

Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer.

Some special therapeutic responses may appear during immunotherapy, such as hyperprogression, pseudoprogression and so on. Dissociated response of immunotherapy has been clinically reported in recent …

Thérapies de Conversion

Jiang, S., Li, X., & Li, J. (2024). Case report: The impact of dissociated response of immunotherapy on the treatment strategy of advanced head and neck cancer.. Front Immunol, 15, 1460480. https://doi.org/10.3389/fimmu.2024.1460480

01/01/2024 Lire →

Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.

PURPOSE: This study aimed to investigate the benefit of conversion therapy for patients with unresectable hepatocellular carcinoma (HCC).PATIENTS AND METHODS: A retrospective cohort study was conducte…

Thérapies de Conversion

Han, R., Gan, L., Sun, L., Lang, M., Tian, X., Zhu, K., Chen, L., Li, G., & Song, T. (2024). Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.. J Hepatocell Carcinoma, 11, 1835-1844. https://doi.org/10.2147/JHC.S482803

01/01/2024 Lire →

Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.

BACKGROUND: This study aimed to assess the effect of adjuvant therapy with different durations in patients with initially unresectable hepatocellular carcinoma (uHCC) after conversion surgery.METHODS:…

Thérapies de Conversion

Lin, Z. T., Wei, S. M., Wu, J. Y., Zhang, Z. B., Wang, S. J., Zhou, J. Y., Luo, M. C., Zeng, Z. X., Ou, X. Y., Fu, Y. K., Li, H., Liu, D. Y., Wu, J. Y., & Yan, M. L. (2024). Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.. J Hepatocell Carcinoma, 11, 1777-1787. https://doi.org/10.2147/JHC.S477019

01/01/2024 Lire →